ACKR3 Human shRNA Plasmid Kit (Locus ID 57007)
CAT#: TR305345
ACKR3 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 2,731.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | ACKR3 Human shRNA Plasmid Kit (Locus ID 57007) |
Locus ID | 57007 |
UniProt ID | P25106 |
Synonyms | chemokine (C-X-C motif) receptor 7; chemokine orphan receptor 1; CMKOR1; GPR159; G protein-coupled receptor; RDC1; RDC1, CMKOR1, GPR159 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | ACKR3 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 57007). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_001047841, NM_020311, NM_020311.1, NM_020311.2, NM_001047841.1, BC036661, BC036661.2, BC008459, BM925428, NM_020311.3 |
Summary | This gene encodes a member of the G-protein coupled receptor family. Although this protein was earlier thought to be a receptor for vasoactive intestinal peptide (VIP), it is now considered to be an orphan receptor, in that its endogenous ligand has not been identified. The protein is also a coreceptor for human immunodeficiency viruses (HIV). Translocations involving this gene and HMGA2 on chromosome 12 have been observed in lipomas. [provided by RefSeq, Jul 2008] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
CXCR7 maintains osteosarcoma invasion after CXCR4 suppression in bone marrow microenvironment
,Han, Y;Wu, C;Wang, J;Liu, N;,
Tumour Biol.
,PubMed ID 28468584
[ACKR3]
|
The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation
,Salazar, N;Muñoz, D;Kallifatidis, G;Singh, RK;Jordà, M;Lokeshwar, BL;,
Mol. Cancer
,PubMed ID 25168820
[ACKR3]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...